Cynata Therapeutics' market value is the price at which a share of Cynata Therapeutics trades on a public exchange. It measures the collective expectations of Cynata Therapeutics Limited investors about its performance. Cynata Therapeutics is trading at 0.14 as of the 1st of February 2025. This is a No Change since the beginning of the trading day. The stock's lowest day price was 0.14. With this module, you can estimate the performance of a buy and hold strategy of Cynata Therapeutics Limited and determine expected loss or profit from investing in Cynata Therapeutics over a given investment horizon. Check out Cynata Therapeutics Correlation, Cynata Therapeutics Volatility and Cynata Therapeutics Alpha and Beta module to complement your research on Cynata Therapeutics.
Please note, there is a significant difference between Cynata Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cynata Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cynata Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cynata Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Cynata Therapeutics' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Cynata Therapeutics.
0.00
01/02/2025
No Change 0.00
0.0
In 31 days
02/01/2025
0.00
If you would invest 0.00 in Cynata Therapeutics on January 2, 2025 and sell it all today you would earn a total of 0.00 from holding Cynata Therapeutics Limited or generate 0.0% return on investment in Cynata Therapeutics over 30 days. Cynata Therapeutics is related to or competes with Forte Biosciences, Cellectar Biosciences, Virax Biolabs, Revelation Biosciences, NRX Pharmaceuticals, Biomx, and Lexaria Bioscience. Cynata Therapeutics Limited, together with its subsidiaries, develops and commercializes a proprietary mesenchymal stem ... More
Cynata Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Cynata Therapeutics' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Cynata Therapeutics Limited upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cynata Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Cynata Therapeutics' standard deviation. In reality, there are many statistical measures that can use Cynata Therapeutics historical prices to predict the future Cynata Therapeutics' volatility.
Cynata Therapeutics secures Sharpe Ratio (or Efficiency) of -0.13, which signifies that the company had a -0.13 % return per unit of risk over the last 3 months. Cynata Therapeutics Limited exposes sixteen different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Cynata Therapeutics' Standard Deviation of 3.24, risk adjusted performance of (0.1), and Mean Deviation of 0.7854 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.0797, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Cynata Therapeutics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Cynata Therapeutics is expected to be smaller as well. At this point, Cynata Therapeutics has a negative expected return of -0.43%. Please make sure to confirm Cynata Therapeutics' variance and kurtosis , to decide if Cynata Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation
0.00
No correlation between past and present
Cynata Therapeutics Limited has no correlation between past and present. Overlapping area represents the amount of predictability between Cynata Therapeutics time series from 2nd of January 2025 to 17th of January 2025 and 17th of January 2025 to 1st of February 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Cynata Therapeutics price movement. The serial correlation of 0.0 indicates that just 0.0% of current Cynata Therapeutics price fluctuation can be explain by its past prices.
Correlation Coefficient
0.0
Spearman Rank Test
0.1
Residual Average
0.0
Price Variance
0.0
Cynata Therapeutics lagged returns against current returns
Autocorrelation, which is Cynata Therapeutics pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Cynata Therapeutics' pink sheet expected returns. We can calculate the autocorrelation of Cynata Therapeutics returns to help us make a trade decision. For example, suppose you find that Cynata Therapeutics has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values
Timeline
Cynata Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Cynata Therapeutics pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Cynata Therapeutics pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Cynata Therapeutics pink sheet over time.
Current vs Lagged Prices
Timeline
Cynata Therapeutics Lagged Returns
When evaluating Cynata Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Cynata Therapeutics pink sheet have on its future price. Cynata Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Cynata Therapeutics autocorrelation shows the relationship between Cynata Therapeutics pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Cynata Therapeutics Limited.
Other Information on Investing in Cynata Pink Sheet
Cynata Therapeutics financial ratios help investors to determine whether Cynata Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cynata with respect to the benefits of owning Cynata Therapeutics security.